Ignite Creation Date:
2025-12-25 @ 4:58 AM
Ignite Modification Date:
2026-06-08 @ 5:59 PM
Study NCT ID:
NCT00915018
Status:
COMPLETED
Last Update Posted:
2018-08-22
First Post:
2009-06-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study Evaluating Neratinib Plus Paclitaxel VS Trastuzumab Plus Paclitaxel In ErbB-2 Positive Advanced Breast Cancer
Sponsor:
Puma Biotechnology, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Breast Cancer | View |